COOPERS OVILIS FOOTVAX SHEEP AND LAMB FOOTROT VACCINE

País: Australia

Idioma: inglés

Fuente: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Ingredientes activos:

CONCENTRATED ANTIGENS OF DICHELOBACTER NODOSUS; LIGHT LIQUID PARAFFIN; THIOMERSAL

Disponible desde:

INTERVET AUSTRALIA PTY LIMITED

Designación común internacional (DCI):

Dichelobacter nodosus(100ug/mL)

formulario farmacéutico:

MISC. VACCINES OR ANTI SERA

Composición:

CONCENTRATED ANTIGENS OF DICHELOBACTER NODOSUS VACCINE-ANTIGEN/ANTIBODY Active 100.0 ug/ml; LIGHT LIQUID PARAFFIN UNGROUPED Other 600.0 ul/ml; THIOMERSAL MERCURY Other 0.05 mg/ml

Unidades en paquete:

100mL; 1L; 250mL; 500mL; 50mL

clase:

VM - Veterinary Medicine

Fabricado por:

INTERVET AUSTRALIA

Grupo terapéutico:

LAMB | SHEEP | EWE | HOGGET | LAMB | OVINE | RAM | WEANER | WETHER

Área terapéutica:

IMMUNOTHERAPY

indicaciones terapéuticas:

FOOTROT - DICHELOBACTER NODOSUS

Resumen del producto:

Poison schedule: 0; Withholding period: WHP: Nil. Trade Advice: Export Slaught er Interval: ESI: Not Required.; Host/pest details: LAMB: [FOOTROT - DICHELOBACTER NODOSUS]; SHEEP: [FOOTROT - DICHELOBACTER NODOSUS]; Poison schedule: 0; Withholding period: ; Host/pest details: LAMB: [FOOTROT - DICHELOBACTER NODOSUS]; SHEEP: [FOOTROT - DICHELOBACTER NODOSUS]; An aid in the control of footrot in sheep and lambs.

Estado de Autorización:

Registered

Fecha de autorización:

2023-07-01

Información para el usuario

U,
pre-press
art
prepared
by
PROD
U
CT
:
SIZE
:
DIMENSIONS:
COLOURS
:
1
7/3/08
FOOTVX
1
DDmL
CARTO
N
162
x
50
x
91
mm
PMS123
• PM
S293
•
BLACK
•
PMS
C
YAN
AP
V
MA
APPROVAL:51170
/1
DDmU1
007
ITEM
N
UMBER:
10019
CCP
No
:
06
/
019A
JOB
BAG
No
:
J/
03
1
6-1A
TYPE
SIZE
CHEC
K U
ST
LOGO
:
15.2mm
KORC
/
SAFID
DIRECTIONS
:
2.3mm
READ
ENCLOSED
LEAFLET
: 2.
Dmm
SMALLEST
REGULATORY
TEXT
: 1.
5mm
1J
JJ
0
0
i1
m
0
@
(j)
co
~
0
0
i1
)>
~
c
)>
r
(J)
N
m
~
I
m
z
1J
JJ
z
-1
m
0
0
z
)>
.j:>.
.......
-·-
-
·-
--- -
- ·- ·
-·--------
- ·-
-
·-·
--
-
- ·-
- ·-
_\
-'-;--
R
EA
D
T
HE
E
NCLO
SED L
EA
FLET
BEFO
RE U
SI
NG
THI
S PR
OD
UCT.
DIMCTlQKS
FDR
USE
1.
AYtNlbc!IMVM
1ft
tc"'SouiJIWIIel.
VIN!tt,
Q-uW4,
Wt.Ura"'MMIa
Nll'bllllanll•lr·
2.
VlcduUelllllllt
penallleclll
10101
dlttr'ct&tf
H..-S.UU.waiu\llttlllut
••PPtMI
frM
till
OtpiMIItrl
IIAo1cultu~ttrRI.uai~PftltKtiMielrd
a.
c.u.ctjCIIItiKIIAunll.llldiPitllctllftloanlfotdttalla.
...........
'lllt
11CdM b
lllii"J'
tl
UIIM I
llfp
lou!
,.IC\Iell
(absclu)
It
tftl
~
If
'fl0d111UN
Ill
I
slp
lf)
CII(
pnpol'l.llll I I
&IN.,_
Wb
l
lt
tlb
..
alp
wll
bt
If
&llcWt
duii!Jollln
molllrllbiiCII,
I
ptn'UIIIIIt
IIMmllb
.UI
f'NIIIIn
111
10111
1 lll
lm
l lt.Al!Kt
Utlllt
p,altleallalfrMUO
II
llle
Ill
tllll11
1td
Drlllsll
tMMdLi
t b
MOCMIIMidld
Ullttambt
11
Cidlllttd l
ll
mt
4-
IWM
klbelnltl•lftt.NurllftCWIIlll!lll1btco•lllfldldlftetNIZZltn'
posallllfWICIId-.ccJUUoadls(Uicluta
)
Uitdatll!l:lble,
l lldtbll sbllllldbtMidld.WIInla]tcllcl
_CllnHU't _
IIIIP
011
tAt
&ldt
ol'
tat
..0
blallll Llll
-~tiM,.
.aMIIII
be
mu.
DliiiHd
tl'
IUIIII
Madlat:
JIOSilbfrlfi!ICl.ld-.cclllallta&ka.
A_.
I&I
IDI
IIIHIIIl&II. 2
.JMOIUilprllf
t.
Uillf
....
UUIINIII'1
1111
iKIIIM&IDHlcbl
ll
llaWMl
VKdutlllllllfUIIn
lol
..
atl&
s
ol'
sl
aul)ttr..,
MWitll
MIO~tllllc
I
ns
weda!.td
lltUI
wcau
tl1aiiii11C.
SlullllCDIIltll
tl
btlmllM-
DN
:
ShHP
and
IAmbs:
lmlii'S
U
8CUWf£0US
IKJ[Ct\ON.
wmtHOUHN
QP
WO
O
IUL
I'IWl
EAtM
CE:
CXPOAISL.AliCHT{R
I
NlERYAL(ts
i
):CSII'IOtlf!
(!
ult
l!d
.
U
wr
Saltty aed
nnt
.ud lalana.U.a

Ficha técnica

COOPERS OVILIS FOOTVAX SHEEP AND LAMB FOOTROT VACCINE
51170/120552
Product Name:
APVMA Approval No:
Label Name:
COOPERS OVILIS FOOTVAX SHEEP AND LAMB FOOTROT VACCINE
Signal Headings:
FOR ANIMAL TREATMENT ONLY
Constituent
Statements:
100 μg/mL of concentrated antigens of: Potency Units
Dichelobacter nodosus Serotype A ≥ 1:400
Dichelobacter nodosus Serotype B1 ≥ 1:400
Dichelobacter nodosus Serotype B2 ≥ 1:400
Dichelobacter nodosus Serotype C ≥ 1:400
Dichelobacter nodosus Serotype D ≥ 1:400
Dichelobacter nodosus Serotype E ≥ 1:400
Dichelobacter nodosus Serotype F ≥ 1:400
Dichelobacter nodosus Serotype G ≥ 1:400
Dichelobacter nodosus Serotype H ≥ 1:400
Dichelobacter nodosus Serotype I ≥ 1:400
Contains 0.05 mg/mL thiomersal as preservative.
Claims:
An aid in the control of footrot in sheep and lambs.
Net Contents:
50 mL
100 mL
250 mL
500 mL
1 L
Directions for Use:
Restraints:
Contraindications:
Precautions: RLP APPROVED
Side Effects:
The vaccine may cause a large local swelling at the site of
vaccination in a significant
proportion of sheep. While this swelling will be of short duration in
most instances,
occasionally they lead to the formation of abscesses which can burst
and discharge. A
permanent blemish may remain in some animals.
Injection site reactions can be particularly noticeable in rams and
British breeds. It is
recommended that rams be vaccinated at least 4-6 weeks before joining.
All sheep should be vaccinated high on the side of the neck behind the
ear – this is
particularly important for ewes with lambs at foot, to ensure there is
little likelihood of lambs
nuzzling potentially infected vaccination sites.
Dosage and
Administration:
Shake well before use.
Use of this vaccine may be restricted in your State or Territory.
Contact your local
Department of Agriculture (or similar) for details.
DOSE: Sheep and Lambs – 1mL by SUBCUTANEOUS INJECTION.
VACCINATION PROGRAMMES:
All sheep in the flock require two doses of FOOTVAX at least six weeks
apart for maximum
effectiveness.
FOOTVAX ca

Ficha de datos de seguridad

PRODUCT NAME: COOPERS FOOTVAX SHEEP AND LAMB FOOTROT
VACCINE
SAFETY DATA SHEET
THIS REVISION ISSUED: NOVEMBER, 2016
PAGE:
1 OF 6
SAFETY DATA SHEET
Issued by: Intervet Australia Pty Limited (trading as MSD Animal
Health) Phone: [phone] (Business Hours)
Poisons Information Centre: 13 11 26 from anywhere in Australia, (0800
764 766 in New Zealand)
CHEMICAL NATURE:
Water suspension of killed bacteria plus minor ingredients.
TRADE NAME:
COOPERS FOOTVAX SHEEP AND LAMB FOOTROT VACCINE
RECOMMENDED USE:
Animal vaccine for use as described on the product label.
APVMA NO:
49668
CREATION DATE:
July, 2009
THIS VERSION ISSUED:
November, 2016
and is valid for 5 years from this date.
POISONS INFORMATION CENTRE: PHONE 13 1126 FROM ANYWHERE IN AUSTRALIA
STATEMENT OF HAZARDOUS NATURE:
THIS PRODUCT IS CLASSIFIED AS:
Not classified as hazardous according to the criteria of SWA.
Not a Dangerous Good according to Australian Dangerous Goods (ADG)
Code, IATA and IMDG/IMSBC criteria.
SUSMP CLASSIFICATION:
None allocated.
ADG CLASSIFICATION:
None allocated. Not a Dangerous Good under the ADG Code.
UN NUMBER:
None allocated
GHS SIGNAL WORD: NONE. NOT HAZARDOUS.
PREVENTION
P102: Keep out of reach of children.
P262: Do not get in eyes, on skin, or on clothing.
P281: Use personal protective equipment as required.
RESPONSE
P337: If eye irritation persists: seek medical attention.
P352: Wash with plenty of soap and water.
P301+P330+P331: IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P370+P378: Not combustible. Use extinguishing media suited to burning
materials.
STORAGE
P402+P404: Store in a dry place. Store in a closed container.
P403+P235: Store in a well-ventilated place. Keep cool.
DISPOSAL
P501: Dispose of contents and containers as specified on the
registered label.
PHYSICAL DESCRIPTION & COLOUR:
A white water-in-oil emulsion vaccine.
ODOUR:
No data.
MAJOR HEALTH HAZARDS:
no significant risk factors have been found for this product.
EMERGENCY OVERVIEW
ISSUED BY: INTERVET AUSTRALIA PTY LIMITED
(TRADING AS MSD ANIMAL HEALTH)
91-10